Cargando…

Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals

BACKGROUND: Maintenance haemodialysis (HD) is associated with a very high cardiovascular risk and the assessment of metabolic cardiovascular risk factors is essential for an adequate diagnosis and management. The aim of the study has been to estimate the biological variation (BV) of serum lipids, ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Corte, Zoraida, Venta, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186598/
https://www.ncbi.nlm.nih.gov/pubmed/32355725
http://dx.doi.org/10.21037/atm.2020.03.26
_version_ 1783526983895875584
author Corte, Zoraida
Venta, Rafael
author_facet Corte, Zoraida
Venta, Rafael
author_sort Corte, Zoraida
collection PubMed
description BACKGROUND: Maintenance haemodialysis (HD) is associated with a very high cardiovascular risk and the assessment of metabolic cardiovascular risk factors is essential for an adequate diagnosis and management. The aim of the study has been to estimate the biological variation (BV) of serum lipids, calcium, inorganic phosphorus, 25-OH vitamin D, C-reactive protein and plasma intact parathyroid hormone (PTHi) and total homocysteine, to evaluate whether HD alter the homeostatic set-point of these magnitudes. METHODS: Blood samples were collected from 18 HD patients in steady-state conditions, one per month during 6 months, and from 11 healthy volunteers at weekly intervals over 5 weeks. BV data were derived using CV-ANOVA. RESULTS: Within-subject coefficients of variation (CVI) and derived reference change values (RCV) estimated in HD patients were significantly higher than in healthy individuals for calcium (CVI =3.8% vs. 2.3%) (RCV =12.6% vs. 7.6%), inorganic phosphorus (13.1% vs. 8.0%) (RCV =38.7% vs. 30.1%) and PTHi (20.3% vs. 11.3%) (RCV =57.5% vs. 34.0%). CONCLUSIONS: For calcium, inorganic phosphorus and PTHi, RCV derived from advanced disease-specific BV data is recommended for the management of bone-mineral disturbances in HD patients. For the rest of cardiovascular risk factors, the use of RCV derived from healthy individuals could be appropriate.
format Online
Article
Text
id pubmed-7186598
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-71865982020-04-30 Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals Corte, Zoraida Venta, Rafael Ann Transl Med Original Article BACKGROUND: Maintenance haemodialysis (HD) is associated with a very high cardiovascular risk and the assessment of metabolic cardiovascular risk factors is essential for an adequate diagnosis and management. The aim of the study has been to estimate the biological variation (BV) of serum lipids, calcium, inorganic phosphorus, 25-OH vitamin D, C-reactive protein and plasma intact parathyroid hormone (PTHi) and total homocysteine, to evaluate whether HD alter the homeostatic set-point of these magnitudes. METHODS: Blood samples were collected from 18 HD patients in steady-state conditions, one per month during 6 months, and from 11 healthy volunteers at weekly intervals over 5 weeks. BV data were derived using CV-ANOVA. RESULTS: Within-subject coefficients of variation (CVI) and derived reference change values (RCV) estimated in HD patients were significantly higher than in healthy individuals for calcium (CVI =3.8% vs. 2.3%) (RCV =12.6% vs. 7.6%), inorganic phosphorus (13.1% vs. 8.0%) (RCV =38.7% vs. 30.1%) and PTHi (20.3% vs. 11.3%) (RCV =57.5% vs. 34.0%). CONCLUSIONS: For calcium, inorganic phosphorus and PTHi, RCV derived from advanced disease-specific BV data is recommended for the management of bone-mineral disturbances in HD patients. For the rest of cardiovascular risk factors, the use of RCV derived from healthy individuals could be appropriate. AME Publishing Company 2020-03 /pmc/articles/PMC7186598/ /pubmed/32355725 http://dx.doi.org/10.21037/atm.2020.03.26 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Corte, Zoraida
Venta, Rafael
Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals
title Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals
title_full Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals
title_fullStr Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals
title_full_unstemmed Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals
title_short Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals
title_sort biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186598/
https://www.ncbi.nlm.nih.gov/pubmed/32355725
http://dx.doi.org/10.21037/atm.2020.03.26
work_keys_str_mv AT cortezoraida biologicalvariationofmetaboliccardiovascularriskfactorsinhaemodialysispatientsandhealthyindividuals
AT ventarafael biologicalvariationofmetaboliccardiovascularriskfactorsinhaemodialysispatientsandhealthyindividuals